384 reports of this reaction
3.9% of all TASIMELTEON reports
#6 most reported adverse reaction
HEADACHE is the #6 most commonly reported adverse reaction for TASIMELTEON, manufactured by Vanda Pharmaceuticals Inc.. There are 384 FDA adverse event reports linking TASIMELTEON to HEADACHE. This represents approximately 3.9% of all 9,924 adverse event reports for this drug.
Patients taking TASIMELTEON who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is moderately reported among TASIMELTEON users, representing a notable but not dominant share of adverse events.
In addition to headache, the following adverse reactions have been reported for TASIMELTEON:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 384 FDA reports for TASIMELTEON. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 3.9% of all adverse event reports for TASIMELTEON, making it a notable side effect.
If you experience headache while taking TASIMELTEON, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.